Contrast-induced nephropathy - Prevention and risk reduction

Nephrology Dialysis Transplantation

Volumn 21, Issue SUPPL. 1, 2006, Pages

  Lameire, Norbert H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Contrast induced nephropathy (CIN); Iodixanol; Iohexol; Iso osmolar; Low osmolar; Osmolality; Renal insufficiency

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN B; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CONTRAST MEDIUM; CREATININE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DIATRIZOATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOPAMIDOL; IOPROMIDE; IOTALAMIC ACID; IOVERSOL; IOXAGLIC ACID; IOXITALAMIC ACID; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; TACROLIMUS; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ALGORITHM; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CREATININE BLOOD LEVEL; CRYSTALLOID; DIABETES MELLITUS; DOSE RESPONSE; DRUG FATALITY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEMODIALYSIS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; HYDRATION; KIDNEY FUNCTION TEST; LOW DRUG DOSE; META ANALYSIS; NEPHROTOXICITY; NONHUMAN; OSMOLALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL PROTECTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; VASODILATATION; VISCOSITY;

CONTRAST MEDIA; HUMANS; KIDNEY DISEASES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 33745522425     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl215     Document Type: Article

References (66)

1. Heyman SN, Rosen S, Brezis M. Radiocontrast nephropathy: A paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994; 2: 153-157
2. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375
3. Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000; 34: 317-322
4. Parfrey PS et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149
5. Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003; 15: 18-22
6. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620
7. Weinrauch LA, Healy RW, Leland OS Jr, Goldstein HH, Kassissieh SD, Libertino JA, Takacs FJ, D'Elia JA. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 1977; 86: 56-59
8. Toms AP, Cash CJ, Linton SJ, Dixon AK. Requests for body computed tomography: Increasing workload, increasing indications and increasing age. Eur Radiol 2001; 11: 2633-2637
9. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515-1519
10. Mehran R et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399
11. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237-1242
12. The world is fast ageing - have we noticed? Available at: http://www.who.int/ageing/en/. Accessed September 13, 2005.
13. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053
14. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: A consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999; 9: 1602-1613
15. Choyke PL, Cady J, DePollar SL, Austin H. Determination of serum creatinine prior to iodinated contrast media: Is it necessary in all patients? Tech Urol 1998; 4: 65-69
16. Thomsen HS, Morcos SK. In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 2005; 15: 749-754
17. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001; 12: 3-9
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
19. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203
20. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, Pichard AD, Satler LF, Wu H, Leon MB. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; 52: 409-416
21. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264
22. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548
23. Alamartine E, Phayphet M, Thibaudin D, Barral FG, Veyret C. Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: Incidence, risk factors, and compliance with recommendations. Eur J Intern Med 2003; 14: 426-431
24. Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anaesthesiol 2004; 18: 37-52
25. Cox CD, Tsikouris JP. Preventing contrast nephropathy: What is the best strategy? A review of the literature. J Clin Pharmacol 2004; 44: 327-337
26. Stevens MA, McCullough PA. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-411
27. Moore RD et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial. Radiology 1992; 182: 649-655
28. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
29. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephropathy in diabetic patients: A randomised study. Indian Heart J 1999; 51: 521-526
30. Khanal S et al. Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 2005; 118: 843-849
31. Porter GA. Radiocontrast-induced nephropathy. Nephrol Dial Transplant 1994; 9 [Suppl 4]: 146-156
32. Itoh Y, Yano T, Sendo T, Oishi R. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005; 97: 473-488
33. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-137
34. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994; 331: 1449-1450
35. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000; 11: 177-182
36. Trivedi HS et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29-C34
37. Mueller C et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336
38. Merten GJ et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004; 291: 2328-2334
39. Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004; 15: 251-260
40. Tepel M et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184
41. Kshirsagar AV et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004; 15: 761-769
42. Nallamothu BK et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004; 117: 938-947
43. Genet S, Kale RK, Baquer NZ. Effects of free radicals on cytosolic creatine kinase activities and protection by antioxidant enzymes and sulfhydryl compounds. Mol Cell Biochem 2000; 210: 23-28
44. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15: 407-410
45. Moon SS, Back SE, Kurkus J, Nilsson-Ehle P. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron 1995; 70: 430-437
46. Frank H et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176-182
47. Vogt B et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-698
48. Marenzi G et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-1340
49. Stacul F. Current iodinated contrast media. Eur Radiol 2001; 11: 690-697
50. Deray G et al. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: Comparison of low- and high-osmolar contrast agents. Am J Nephrol 1991; 11: 309-312
51. Harris KG, Smith TP, Cragg AH, Lemke JH. Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents. Radiology 1991; 179: 849-852
52. Taliercio CP et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 1991; 17: 384-390
53. Barrett BJ et al. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 1992; 41: 1274-1279
54. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-178
55. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997; 203: 605-610
56. Esplugas E, Cequier A, Gomez-Hospital JA, Del Blanco BG, Jara F. Comparative tolerability of contrast media used for coronary interventions. Drug Saf 2002; 25: 1079-1098
57. Rudnick MR et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261
58. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999; 72: 701-703
59. Aspelin P et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499
60. Ueda J, Nygren A, Hansell P, Erikson U. Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Acta Radiol 1992; 33: 596-599
61. Freeman RV et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073
62. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501-504
63. Briguori C et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298-303
64. Tadros GM et al. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invasive Cardiol 2005; 17: 211-215
65. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461-1471
66. Mehran R et al. A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2003; 41: 37A